KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Total Debt (2016 - 2023)

Medpace Holdings (MEDP) has disclosed Total Debt for 7 consecutive years, with $55.0 million as the latest value for Q2 2023.

  • For the quarter ending Q2 2023, Total Debt fell 88.99% year-over-year to $55.0 million, compared with a TTM value of $55.0 million through Jun 2023, down 88.99%, and an annual FY2022 reading of $50.0 million, changed N/A over the prior year.
  • Total Debt was $55.0 million for Q2 2023 at Medpace Holdings, down from $115.0 million in the prior quarter.
  • Across five years, Total Debt topped out at $499.4 million in Q2 2022 and bottomed at $50.0 million in Q4 2022.
  • Average Total Debt over 3 years is $152.5 million, with a median of $85.4 million recorded in 2019.
  • The sharpest move saw Total Debt plummeted 71.77% in 2019, then crashed 88.99% in 2023.
  • Year by year, Total Debt stood at $55.8 million in 2019, then decreased by 10.36% to $50.0 million in 2022, then increased by 10.0% to $55.0 million in 2023.
  • Business Quant data shows Total Debt for MEDP at $55.0 million in Q2 2023, $115.0 million in Q1 2023, and $50.0 million in Q4 2022.